Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | EYA2 | O00167 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | BHMT | Q93088 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27092874 | 0.86 | TDP1 (0.38) | MAOBCYP1A2TDP1EYA2APP | |
| SCHEMBL27092883 | 0.86 | TDP1 (0.38) | MAOBCYP1A2TDP1EYA2APP | |
| SCHEMBL20969060 | 0.83 | TSHR (0.43) | TP53MAOBTDP1EYA2APP | |
| SCHEMBL10207190 | 0.80 | TP53 (0.38) | TP53TDP1ADRA1ADRD3SLC6A3 | |
| SCHEMBL16396821 | 0.80 | TP53 (0.38) | TP53CYP1A2TDP1EYA2APP | |
| SCHEMBL19210047 | 0.79 | TP53 (0.33) | TP53CYP1A2TDP1EYA2APP | |
| SCHEMBL19210044 | 0.79 | TP53 (0.33) | TP53CYP1A2TDP1EYA2APP | |
| SCHEMBL893034 | 0.79 | — | — | |
| SCHEMBL29554680 | 0.78 | TP53 (0.36) | TP53CYP1A2TDP1EYA2APP | |
| SCHEMBL14926794 | 0.75 | TP53 (0.33) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9416095-B2 | Salts, crystals, complexes, and derivatives of threonine diacetic acid, a process to prepare threonine diacetic acid, and the use thereof | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-08-16 | — | — | US | disclosed |
| US-20160159730-A1 | New Salts, Crystals, Complexes, and Derivatives of Threonine Diacetic Acid, a Process to Prepare threonine Diacetic Acid, and the Use Thereof | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159730-A1 | New Salts, Crystals, Complexes, and Derivatives of Threonine Diacetic Acid, a Process to Prepare threonine Diacetic Acid, and the Use Thereof | LRRK2, SKP2, PLK1 | TP53 275/4885MAOB 3685/4885CYP1A2 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.